Journal article icon

Journal article

Predictive factors for time to progression after hyperthermic mitomycin C treatment for high-risk non-muscle invasive urothelial carcinoma of the bladder: an observational cohort study of 97 patients

Abstract:

Hyperthermic mitomycin (HM) is a novel treatment modality for selected patients with high-risk non-muscle invasive bladder cancer (NMIBC). We sought to determine predictors of response to this therapy.A longitudinal, cohort study of 97 patients with high-risk NMIBC treated with ≥4 HM instillations on a prophylactic schedule was conducted. The primary outcome was time-to-progression survival; secondary outcomes were overall survival, cancer-specific survival, and adverse events. Descriptive st...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1159/000435788

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Surgical Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Surgical Sciences, NDORMS, CSM
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS, CSM
Role:
Author
Expand authors...
Publisher:
Karger Publisher's website
Journal:
Urologia Internationalis Journal website
Volume:
96
Issue:
1
Pages:
83-90
Publication date:
2016-01-01
DOI:
EISSN:
1423-0399
ISSN:
0042-1138
URN:
uuid:646cce0b-5e4e-4506-8798-da419cb7feab
Source identifiers:
539123
Local pid:
pubs:539123

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP